The Effect of Midazolam Premedication on Copeptine Concentration in Blood
NCT ID: NCT03474939
Last Updated: 2019-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2017-04-03
2019-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Midazolam on the Quality of Postoperative Recovery
NCT01993459
Effect of Oral Dexmedetomidine, Ketamine, Or Midazolam as Preioperative Medications.
NCT05874245
Intranasal Midazolam in Children as a Pre-Operative Sedative
NCT02314546
Assessing the Effectiveness of Midazolam Premedication
NCT03325335
Effects of Dexmedetomidine on Cognitive Outcome and Brain Injury Markers
NCT03585452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MIDAZOLAM
Patients receive midazolam 7,5mg night before and 60 minutes prior to surgery as part of preanesthetic medication
Midazolam Oral Tablet
Midazolam Oral tablet
PLACEBO
Patients receive 1000mg Glucose tablets night before and 60 minutes prior to surgery during premedication
Placebo Oral Tablet
Glucose 1000mg tablet night before surgery and 60 minutes before surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Midazolam Oral Tablet
Midazolam Oral tablet
Placebo Oral Tablet
Glucose 1000mg tablet night before surgery and 60 minutes before surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with no chronić illness and considered ASA 1 by anesthesiologist
* Patients with mild and controlled chronic illness considered ASA 2 by anesthesiologist
Exclusion Criteria
* Chronic illness requiring intense treatment or uncontrolled illness (ASA 3 or more)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Warsaw
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marek Janiak
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
I Department of Anesthesiology and Intensive Care Medical University of Warsaw
Warsaw, Masovian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIDPRECOP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.